Clinical Trial Update: Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating the effects of empagliflozin on cardiac structure in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Diabetes, Cardiovascular Disease | Phase 4 | Status: UNKNOWN